21 CFR 347.3
§ 347.3 Definitions.
United States · 21 CFR — Food and Drugs · Status: effective
Cite this
- Citation
- 21 CFR 347.3, § 347.3 Definitions, United States, version 1 as recorded 2026-07-09, yourstate.us, https://yourstate.us/provision/86631
- Permanent ID
ys:prov:86631@1- SHA-256
7eeb178bfea9cd26d51d222d8c4cd69f1233955f28a62331b39710bb977ea74f
The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.
Full text
As used in this part:
Astringent drug product. A drug product applied to the skin or mucous membranes for a local and limited protein coagulant effect.
Lip protectant drug product. A drug product that temporarily prevents dryness and helps relieve chapping of the exposed surfaces of the lips; traditionally called “lip balm.”
Poison ivy, oak, sumac dermatitis. An allergic contact dermatitis due to exposure to plants of the genus Rhus (poison ivy, poison oak, poison sumac), which contain urushiol, a potent skin-sensitizer.
Skin protectant drug product. A drug product that temporarily protects injured or exposed skin or mucous membrane surfaces from harmful or annoying stimuli, and may help provide relief to such surfaces.
Legislative history
This is a federal regulation, adopted through agency rulemaking under the Administrative Procedure Act — not enacted by a recorded vote of Congress.